Octave Bioscience
Menlo Park, California, United States
How Octave Bioscience hit $19.1M revenue with a 113 person team in 2023.
Octave is revolutionizing care management by introducing a groundbreaking Care Management Platform. The team has devised innovative measurement tools that integrate with sophisticated analytical data models to enhance decision-making, drive better outcomes, and reduce costs. Focusing initially on multiple sclerosis (MS), Octave recognizes the importance of enhancing care management to significantly improve patient outcomes. By prioritizing advanced measurement techniques, Octave aims to address the considerable challenges faced by patients with MS. Through its unique approach that combines biological, clinical, and economic data with cutting-edge analytics, contextualization, and AI, Octave is delivering actionable insights to empower stakeholders including physicians, patients, payers, and pharmaceutical companies.
$19.1M
2023 Revenue
-----
YOY
$48.5M
Funding
Octave Bioscience Revenue
In 2023, Octave Bioscience revenue run rate hit $19.1M in revenue.
-
2023
Octave Bioscience hit $19.1M in revenue in 2023
-
Octave Bioscience launched in with $0 revenue
Octave Bioscience Funding History
No funding has been reported for Octave Bioscience yet.
Team
Octave Bioscience has 113 total employees.
| DISTRIBUTION | QTY |
|---|---|
| Total team size | 113 |
Founder / CEO
William Hagstrom
Q&A
-
What's your age?
-
-
Favorite online tool?
-
-
Favorite book?
-
-
Favorite CEO?
-
-
Advice for 20 year old self
-
Customers
Churn
Octave Bioscience Executives
| Name | Position | Working Email | Personal Email |
|---|---|---|---|
| William Hagstrom | CEO | - | - |
Octave Bioscience Employees
| Name | Position | Working Email | Personal Email |
|---|---|---|---|
| William Hagstrom | CEO | - | - |
Frequently Asked Questions about Octave Bioscience
-
When was Octave Bioscience founded?
Octave Bioscience was founded in .
-
How much revenue does Octave Bioscience generate?
Octave Bioscience generates $19.1M in revenue.
-
Who is the CEO of Octave Bioscience
The CEO of Octave Bioscience is William Hagstrom.
-
How much funding does Octave Bioscience have?
Octave Bioscience raised $48.5M.
-
How many employees does Octave Bioscience have?
Octave Bioscience has 113 employees.
-
Where is Octave Bioscience headquarters?
Octave Bioscience is headquartered at Menlo Park, California, United States
People Also Viewed
BookMyForex.com
Provider of a money exchange and foreign remittance transfer platform. The company provides an online platform to provide forex services, multi-currency cards, cash remittance and travel insurance.
Synesis It Inc
Welcome to the Synesis IT LinkedIn Company page! We're so glad you found us. We created this page to provide you easy access - within LinkedIn - to update about newest latest industry news, free webinars, and resources.
Quixy
Quixy is a no-code platform that empowers business users with no programming skills to automate workflows and build enterprise-grade applications using simple drag and drop.
SpotDraft
Provider of an artificial intelligence-powered platform designed to draft and execute legal contracts. The company's platform advices businesses about their existing contracts, without any additional cost or fees and sends customized reminders and invoices, enabling businesses to get payment faster and avoid all the confusing paperwork.
PrivateCircle
PrivateCircle is a Research + Connect marketplace platform, that brings together Growth companies, VC & PE funds as well as HNIs looking for exposure to private equity investments. RESEARCH : We enable our customers to conduct on-demand analytics on our platform, that truly helps them identify the right counterparties. ACCESS: Once identified, our customers can connect with the right people with just one-click. ENGAGE: Our platform enables secure sharing of documents/ presentations all at one place, to enable truly meaningful engagement.
Fullcontact
FullContact Inc. FullContact received considerable press in July 2012 when it announced a "Paid Paid Vacation" policy.